Frequency Therapeutics is pioneering a new category in regenerative medicine. Frequency’s progenitor cell activation platform aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body. The Company’s lead preclinical program is designed to activate oligodendrocyte precursor cells with the goal of driving remyelination and potential functional recovery for individuals living with multiple sclerosis.
View Top Employees from Frequency TherapeuticsWebsite | http://www.frequencytx.com/ |
Ticker | FREQ |
Revenue | $9.4 million |
Funding | $264.3 million |
Employees | 53 (53 on RocketReach) |
Founded | 2015 |
Address | 75 Hayden Avenue Suite 300, Lexington, Massachusetts 02421, US |
Phone | (781) 315-4600 |
Technologies |
JavaScript,
HTML,
PHP
+31 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Genetics, Health Care, Medical |
Competitors | Annexon Biosciences, Concert Pharmaceuticals, Inc., Galera Therapeutics, Inc., GlycoMimetics, PMV Pharmaceuticals, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Frequency Therapeutics employee's phone or email?
The Frequency Therapeutics annual revenue was $9.4 million in 2024.
Chris Loose is the Co-Founder and Chief Scientific Officer of Frequency Therapeutics.
53 people are employed at Frequency Therapeutics.
Frequency Therapeutics is based in Lexington, Massachusetts.
The NAICS codes for Frequency Therapeutics are [5417, 541, 541714, 54, 54171].
The SIC codes for Frequency Therapeutics are [873, 87].